TipRanks
Go Ultimate55% OFF

Bunge Global (BGN) AI Stock Analysis

MX:BGN

Bunge Global

(BMV:BGN)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Integrated global agribusiness platformBunge’s vertically integrated network connects farm origination with storage, transportation, processing and downstream ingredients. This breadth supports logistical optimization, product diversification and regional supply-demand arbitrage, creating a durable platform that can serve food, feed and renewable-fuels customers.
Negative Factors
Weak current cash conversionNegative operating and free cash flow reduces the company’s ability to fund investment, dividends and debt service internally, even while reported earnings remain positive. Elevated working-capital requirements and investment needs could keep cash conversion pressured and limit financial flexibility over coming quarters.

Bunge Global (BGN) vs. SPDR S&P 500 ETF (SPY)

-10%0%10%20%30%40%50%60%MX:BGN+8.01%SPY+12.58%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
MXN 18.10B
Dividend Yield
2.51%
Average Volume (3M)
―
Price to Earnings (P/E)
15.8
Beta (1Y)
0.08
Revenue Growth
40.62%
EPS Growth
-43.90%
Country
Mexico
Employees
34,000
Sector
Consumer Defensive
Sector Strength
62
Industry
Agricultural Farm Products

Bunge Global Business Overview & Revenue Model

Company Description

Bunge Global S.A., established in 1818 and headquartered in St. Louis, Missouri, operates as a prominent international agribusiness and food corporation. Its diverse operations are categorized into four main divisions: Agribusiness, Refined and Speci...

Bunge Global Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:0.00%|Next Earnings Date:Feb 09, 2027
Earnings Call SentimentPositive

The call was broadly positive. Strong adjusted earnings, improved soybean and softseed processing, progress on Viterra synergies, project completion, strong liquidity and maintained EPS guidance outweighed lower Tropical Oils and Specialty Ingredients results, higher interest expense, elevated working capital and substantial geopolitical, policy and weather uncertainty.

Positive Updates

Strong Third-Quarter Adjusted Earnings
Reported third-quarter EPS was $1.64 versus $0.86 in the third quarter of 2025. Adjusted EPS increased to $2.56 from $2.27, while adjusted segment EBIT rose to $997 million from $924 million.

Negative Updates

Unfavorable Third-Quarter Notable Items
Reported third-quarter results included an unfavorable $0.28 per-share mark-to-market timing difference and an unfavorable $0.64 per-share impact from notable items: $0.43 related to the announced sale of two Brazilian sugarcane mills, $0.11 related to Ukraine-Russia conflict charges and $0.10 related to Viterra integration costs.

Company Guidance

Bunge is maintaining full year 2026 adjusted EPS in the range of $9.25 to $9.75; Soybean Processing and Refining segment results are forecasted to be lower -- slightly lower, Softseed Processing and Refining segment results are forecasted to be unchanged, Tropical Oils and Specialty Ingredients results are forecasted to be lower, Grain Merchandising and Milling segment results are forecasted to be higher, and Corporate and Other results are expected to be unchanged. The company expects an adjusted annual effective tax rate in the range of 23% to 25%, net interest expense in the range of $640 million to $670 million, capital expenditures toward the higher end of the $1.5 billion to $1.7 billion range, and depreciation and amortization of approximately $975 million; it also expects elevated levels of working capital through the end of the year and likely early into next year. For 2027, the company expects about a $0.50 a share improvement in earnings contribution from its growth CapEx projects, about $0.50 a share from additional cost synergies over 2026 and about another $0.50 a share from commercial synergies, while cost synergies are expected to increase from $250 million to $350 million eventually, with approximately $190 million previously expected in 2026 revised to just a little north of $200 million for the year.

Bunge Global Risk Analysis

Bunge Global disclosed 29 risk factors in its most recent earnings report. Bunge Global reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Bunge Global Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

MX:BGN against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ANDEANDE65Neutral$2.18B12.2814.15%1.25%-5.20%120.12%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
ADMADM62Neutral$37.07B20.767.73%2.73%-0.79%60.09%
DOLEDOLE54Neutral$1.23B17.024.38%2.55%8.32%208.64%
AGROAGRO49Neutral$1.40B29.413.03%3.10%7.20%-10.41%

* Consumer Defensive Sector Average

Performance Comparison

0%25%50%75%100%MX:BGNAGROADMANDEAFRIDOLEDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:BGN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:BGNBunge Global Sa1812.01134.318.01%
AGROAdecoagro9.561.9926.24%
ADMArcher-Daniels-Midland Company75.7717.3629.71%
ANDEThe Andersons63.9718.1439.58%
AFRIForafric Global Plc12.382.7929.09%
DOLEDole Plc13.310.695.43%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.